Finland· FI-REL-REL354
Microlax
A natriumlaurylsulfoacetat, inkl. kombinationen product containing sodium citrate + sodium lauryl sulfoacetate + sorbitol, registered in Finland by McNeil / JNTL Consumer Health (Finland) Oy. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Natriumlaurylsulfoacetat, inkl. kombinationen is registered in 9 of 19 countries.
Countries holding a registration under ATC A06AG11 (natriumlaurylsulfoacetat, inkl. kombinationen), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Natriumlaurylsulfoacetat, inkl. kombinationen · ATC A06AG11
9 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Sodium citrate + Sodium lauryl sulfoacetate + Sorbitol
- Manufacturer
- McNeil / JNTL Consumer Health (Finland) Oy
- Country
- Finland (FI)
- ATC code
- A06AG11
- ATC class
- Natriumlaurylsulfoacetat, inkl. Kombinationen
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Natriumlaurylsulfoacetat, inkl. kombinationen in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Austria · Microlax
- Estonia · Microlax
- Lithuania · Microlax
- Latvia · Microlax
- Netherlands · Microlax
- Norway · Microlax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/06799409-6399-4878-8044-24c6b6d8b82e GET /v1/drugs/06799409-6399-4878-8044-24c6b6d8b82e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1",
"form": "peräruiskeliuos",
"route": "Peräsuoleen",
"ddd_unit": "ED",
"strength": null,
"atc_label": "lauryylisulfaatti ja lauryylisulfaattia sisältävät yhdistelmävalmisteet",
"ma_number": "3205",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL354",
"authorised_at": "1966-03-30"
}See everything about natriumlaurylsulfoacetat, inkl. kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.